NCT05860686

Brief Summary

Many authors have advocated different methods of treating alveolar osteitis. Despite many years of research, however, little progress has been made and so a study with large enough sample and standard outcome measures is warranted. Goal of this study is assess the effect of postoperative use of a monoject syringe on postoperative complaints after surgical removal of a lower third molar.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 16, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

7 months

First QC Date

May 8, 2023

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • NRS pain

    pain score

    7 days after treatment

Study Arms (2)

No rinsing

ACTIVE COMPARATOR
Other: Monoject syringe

Monoject rinsing

EXPERIMENTAL
Other: Monoject syringe

Interventions

monoject syringe is used to clean the wound

Monoject rinsingNo rinsing

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria: patients over 18 years of age (non-smoking) referred for removal of a wisdom tooth in the mandible. Patient has ASA I.

You may not qualify if:

  • Patient is younger than 18 years
  • Patient has an ASA of II,III en IV
  • Patient has only one maxillary third molar that needs to be extracted/removed
  • Patient has an active pericoronitis
  • In case of planned coronectomy
  • Patient has trismus
  • Patient has chronic pain
  • Patient is pregnant
  • Patient has a known allergy for ibuprofen of other NSAID's
  • Patient has a known allergy for articaine of epinefrine
  • Intra-operative compilations for example excessive bleeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Double blind randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Oral an Maxillo facial surgeon

Study Record Dates

First Submitted

May 8, 2023

First Posted

May 16, 2023

Study Start

June 1, 2023

Primary Completion

December 31, 2023

Study Completion

May 1, 2024

Last Updated

May 16, 2023

Record last verified: 2023-05